Matinas BioPharma Hldgs's Earnings: A Preview
Portfolio Pulse from Benzinga Insights
Matinas BioPharma Hldgs (AMEX:MTNB) is set to release its latest quarterly earnings report on November 8, 2023. Analysts estimate an earnings per share (EPS) of $-0.03. The company's past performance shows a trend of missing EPS estimates, which has led to significant drops in share price. The company's shares are currently trading at $0.2516 and have seen a 60.21% decrease over the last 52-week period.
November 07, 2023 | 6:02 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Matinas BioPharma Hldgs is expected to report an EPS of $-0.03. The company's history of missing EPS estimates and the subsequent negative impact on its share price could potentially influence investor sentiment.
The company's history of missing EPS estimates has previously led to significant drops in its share price. Given this trend, and the fact that the company's shares have been on a downward trajectory over the past year, it is likely that the upcoming earnings report could have a negative impact on the company's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100